Results: 1-11 |
Results: 11

Authors: Yamamoto, A Tanaka, H Okumura, S Shinsako, K Ito, M Yamashita, M Okada, N Fujita, T Muranishi, S
Citation: A. Yamamoto et al., Evaluation of insulin permeability and effects of absorption enhancers on its permeability by an in vitro pulmonary epithelial system using Xenopus pulmonary membrane, BIOL PHAR B, 24(4), 2001, pp. 385-389

Authors: Yamamoto, A Iseki, T Ochi-Sugiyama, M Okada, N Fujita, T Muranishi, S
Citation: A. Yamamoto et al., Absorption of water-soluble compounds with different molecular weights and[Asu(1.7)]-eel calcitonin from various mucosal administration sites, J CONTR REL, 76(3), 2001, pp. 363-374

Authors: Tozaki, H Nishioka, J Komoike, J Okada, N Fujita, T Muranishi, S Kim, SI Terashima, H Yamamoto, A
Citation: H. Tozaki et al., Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery, J PHARM SCI, 90(1), 2001, pp. 89-97

Authors: Uchiyama, T Kotani, A Tatsumi, H Kishida, T Okamoto, A Okada, N Murakami, M Fujita, T Fujiwara, Y Kiso, Y Muranishi, S Yamamoto, A
Citation: T. Uchiyama et al., Development of novel lipophilic derivatives of DADLE (Leucine enkephalin analogue): Intestinal permeability characteristics of DADLE derivatives in rats, PHARM RES, 17(12), 2000, pp. 1461-1467

Authors: Quan, YS Kuribayashi, D Nakamoto, Y Doi, M Muranishi, S Fujita, T Yamamoto, A
Citation: Ys. Quan et al., Electrophysiological studies on the mechanism for enhanced intestinal transport of water-soluble compounds by antibiotic peptide bacitracin, BIOL PHAR B, 22(8), 1999, pp. 841-845

Authors: Sasaki, I Tozaki, H Matsumoto, K Ito, Y Fujita, T Murakami, M Muranishi, S Yamamoto, A
Citation: I. Sasaki et al., Development of an oral formulation of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue, using n-lauryl-beta-D-maltopyranoside as an absorption enhancer, BIOL PHAR B, 22(6), 1999, pp. 611-615

Authors: Tozaki, H Fujita, T Odoriba, T Terabe, A Suzuki, T Tanaka, C Okabe, S Muranishi, S Yamamoto, A
Citation: H. Tozaki et al., Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: Therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats, LIFE SCI, 64(13), 1999, pp. 1155-1162

Authors: Tozaki, H Fujita, T Komoike, J Kim, SI Terashima, H Muranishi, S Okabe, S Yamamoto, A
Citation: H. Tozaki et al., Colon-specific delivery of budesonide with azopolymer-coated pellets: Therapeutic effects of budesonide with a novel dosage form against 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats, J PHARM PHA, 51(3), 1999, pp. 257-261

Authors: Uchiyama, T Sugiyama, T Quan, YS Kotani, A Okada, N Fujita, T Muranishi, S Yamamoto, A
Citation: T. Uchiyama et al., Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: Their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside, J PHARM PHA, 51(11), 1999, pp. 1241-1250

Authors: Tozaki, H Fujita, T Odoriba, T Terabe, A Okabe, S Muranishi, S Yamamoto, A
Citation: H. Tozaki et al., Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats, J PHARM PHA, 51(10), 1999, pp. 1107-1112

Authors: Tozaki, H Odoriba, T Iseki, T Taniguchi, T Fujita, T Murakami, M Muranishi, S Yamamoto, A
Citation: H. Tozaki et al., Use of protease inhibitors to improve calcitonin absorption from the smalland large intestine in rats, J PHARM PHA, 50(8), 1998, pp. 913-920
Risultati: 1-11 |